SKI Market

A+| A| A-|

Indian Indices

Sensex

73,983.18 64.42
( 0.09%)

Global Indices

Nasdaq

50,884.98 77.97
(0.15%)

Dow Jones

7,407.31 -19.42
(-0.26%)

Hang Seng

64,234.22 -1,182.41
(-1.81%)

Nikkei 225

10,254.58 27.25
(0.27%)

Forex

USD-INR

95.53 0.30
(0.32%)

EUR-INR

110.14 0.47
(0.43%)

GBP-INR

127.43 0.45
(0.36%)

JPY-INR

0.60 0.00
(0.41%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dabur India Ltd

Industry : Personal Care - Indian

BSE Code

ISIN Demat

Book Value()

500096

INE016A01026

42.4291841

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DABUR

50.31

75588.11

EPS(TTM)

Face Value()

Div & Yield %

8.47

1.94

Back

au financiers (india) ltd

Indrayani Biotech consolidated net profit declines 25.41% in the September 2025 quarter

Dec 16,2025

Net profit of Indrayani Biotech declined 25.41% to Rs 0.91 crore in the quarter ended September 2025 as against Rs 1.22 crore during the previous quarter ended September 2024. Sales rose 16.68% to Rs 35.95 crore in the quarter ended September 2025 as against Rs 30.81 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	35.95	30.81	17
OPM %	6.82	16.59	-
PBDT	2.36	3.99	-41
PBT	1.06	1.20	-12
NP	0.91	1.22	-25

73,983.18 64.42 ( 0.09%)

50,884.98 77.97 (0.15%)

7,407.31 -19.42 (-0.26%)

64,234.22 -1,182.41 (-1.81%)

10,254.58 27.25 (0.27%)

95.53 0.30 (0.32%)

110.14 0.47 (0.43%)

127.43 0.45 (0.36%)

0.60 0.00 (0.41%)